Your browser doesn't support javascript.
loading
Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants.
Hu, Chao; Shen, Meiying; Han, Xiaojian; Chen, Qian; Li, Luo; Chen, Siyin; Zhang, Jing; Gao, Fengxia; Wang, Wang; Wang, Yingming; Li, Tingting; Li, Shenglong; Huang, Jingjing; Wang, Jianwei; Zhu, Ju; Chen, Dan; Wu, Qingchen; Tao, Kun; Pang, Da; Jin, Aishun.
Afiliação
  • Hu C; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Shen M; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Han X; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, PR China.
  • Chen Q; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Li L; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Chen S; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Zhang J; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Gao F; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Wang W; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Wang Y; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Li T; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Li S; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Huang J; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Wang J; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Zhu J; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Chen D; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Wu Q; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Tao K; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Pang D; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Jin A; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Genes Dis ; 9(1): 216-229, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34222571
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Genes Dis Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Genes Dis Ano de publicação: 2022 Tipo de documento: Article